Unraveling the role of HER2 mutant alleles in breast cancer
A new editorial paper was published in Oncotarget's Volume 14 on October 31, 2023, entitled, "The uncharted role of HER2 mutant alleles in breast cancer."
Three new studies show low-dose atropine can help slow myopia in children
Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050.
Children need to be screened for vision problems as often as adults with sickle cell disease, study suggests
Sickle cell disease is a rare, inherited disorder in which the red blood cells become hard, sticky, and change shape, resembling the farm tool.
Firearm injuries among children take an enormous mental, behavioral health toll on victims and their families
The alarming increase in firearm injuries to children and adolescents in the United States has taken an enormous mental and behavioral health toll on victims, survivors, and their families, with…
Study provides insights into the challenges faced by American moms in the year after birth
Maternal mortality in the U.S. is on the rise and more than half of maternal deaths occur in the postpartum year.
Individuals with genetic predisposition for physical activity have fewer cardiovascular risk factors
In a study conducted at the University of Jyväskylä's Faculty of Sport and Health Sciences, it was found that individuals with a genetic predisposition for higher levels of physical activity…
A step closer to injection-free diabetes care: Innovation in insulin-producing cells
A team has developed a new step to improve the process for creating insulin-producing pancreatic cells from a patient's own stem cells, bringing the prospect of injection-free treatment closer for…
Yabing Chen receives NIH grants to advance vascular disease research
Yabing Chen, Ph.D., has been awarded two National Institutes of Health grants totaling more than $5 million to further her research into vascular diseases ranging from hardening of the arteries…
Targeted drug may offer a new treatment option for patients with relapsed blood cancer
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James),…
Researchers identify a ‘Threshold of Immunity’ to SARS-CoV-2
How much immunity do we need against COVID-19? New international research led by scientists in Ireland and published in Nature Communications, has identified a 'Threshold of Immunity' to SARS-CoV-2.